Stopping a trial early in oncology: for patients or for industry?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/19/7/1347/909721/mdn042.pdf
Reference35 articles.
1. Guideline on the evaluation of anticancer medicinal products in man (CPMP/EWP/205/95/Rev.3/Corr.2);The European Medicines Agency,2005
2. Haematological anticancer drugs in Europe: any added value at the time of approval?;Bertele’;Eur J Clin Pharmacol,2007
3. Ten years of marketing approvals of anticancer drugs in Europe: regulatory policy and guidance documents need to find a balance between different pressures;Apolone;Br J Cancer,2005
4. End points and United States Food and Drug Administration approval of oncology drugs;Johnson;J Clin Oncol,2003
5. Availability of comparative trials for the assessment of new medicines in the European Union at the moment of market authorization;van Luijn;Br J Clin Pharmacol,2007
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Lost in Translation: Why Are Rates of Hypertension Control Getting Worse Over Time?;American Journal of Kidney Diseases;2024-01
2. Pharmaceuticals as a market for “lemons”: Theory and practice;Social Science & Medicine;2021-01
3. How can health economics be used in the design and analysis of adaptive clinical trials? A qualitative analysis;Trials;2020-03-06
4. Anticancer drug prices and clinical outcomes: a cross-sectional study in Italy;BMJ Open;2019-12
5. Effect of Crossover in Oncology Clinical Trials on Evidence Levels in Early Benefit Assessment in Germany;Value in Health;2018-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3